Literature DB >> 17440818

Smac/DIABLO is required for effector caspase activation during apoptosis in human cells.

Krishnaraj Rajalingam1, Monique Oswald, Kathleen Gottschalk, Thomas Rudel.   

Abstract

Mitochondria play a pivotal role during stress-induced apoptosis as several proapoptotic proteins are released to the cytosol to activate caspases. Smac/DIABLO is one of the proapoptotic proteins released from the mitochondria and has been shown to inactivate IAPs. However, gene knockout studies in mice revealed a redundant role for Smac during development and cell death. By applying RNA interference-mediated loss of function approach, we demonstrate that Smac/DIABLO is required for the activation of effector but not initiator caspases during stress and receptor-mediated cell death in HeLa cells. Cells with reduced Smac resist apoptosis and retained clonogenicity. Our results suggest an obligatory role for Smac/DIABLO in these tumor cells during several pathways of apoptosis induction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440818     DOI: 10.1007/s10495-007-0067-7

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  11 in total

1.  Essential role of TAK1 in regulating mantle cell lymphoma survival.

Authors:  Daniela Buglio; Sangeetha Palakurthi; Kate Byth; Francisco Vega; Dorin Toader; Jamal Saeh; Sattva S Neelapu; Anas Younes
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

2.  Activation of Multiple Molecular Mechanisms for Increasing Apoptosis in Human Glioblastoma T98G Xenograft.

Authors:  Surajit Karmakar; Subhasree Roy Choudhury; Naren L Banik; Swapan K Ray
Journal:  J Cancer Sci Ther       Date:  2010-06-26

Review 3.  Clinico-pathologic relevance of Survivin splice variant expression in cancer.

Authors:  Rosalia de Necochea-Campion; Chien-Shing Chen; Saied Mirshahidi; Frank D Howard; Nathan R Wall
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

4.  Survivin monomer plays an essential role in apoptosis regulation.

Authors:  Marat S Pavlyukov; Nadezhda V Antipova; Maria V Balashova; Tatjana V Vinogradova; Evgenij P Kopantzev; Mihail I Shakhparonov
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

Review 5.  Programmed cell death pathways and current antitumor targets.

Authors:  Mei Lan Tan; Jer Ping Ooi; Nawfal Ismail; Ahmed Ismail Hassan Moad; Tengku Sifzizul Tengku Muhammad
Journal:  Pharm Res       Date:  2009-04-30       Impact factor: 4.200

6.  Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia.

Authors:  Samy A F Morad; Terence E Ryan; P Darrell Neufer; Tonya N Zeczycki; Traci S Davis; Matthew R MacDougall; Todd E Fox; Su-Fern Tan; David J Feith; Thomas P Loughran; Mark Kester; David F Claxton; Brian M Barth; Tye G Deering; Myles C Cabot
Journal:  J Lipid Res       Date:  2016-05-02       Impact factor: 5.922

7.  Chlamydia psittaci-Infected Dendritic Cells Communicate with NK Cells via Exosomes To Activate Antibacterial Immunity.

Authors:  Nadine Radomski; Axel Karger; Kati Franzke; Elisabeth Liebler-Tenorio; Rico Jahnke; Svea Matthiesen; Michael R Knittler
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

8.  Flotillin-2 modulates fas signaling mediated apoptosis after hyperoxia in lung epithelial cells.

Authors:  Shuquan Wei; Hyung-Geun Moon; Yijie Zheng; Xiaoliang Liang; Chang Hyeok An; Yang Jin
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

9.  Bim and Bmf synergize to induce apoptosis in Neisseria gonorrhoeae infection.

Authors:  Oliver Kepp; Kathleen Gottschalk; Yuri Churin; Krishnaraj Rajalingam; Volker Brinkmann; Nikolaus Machuy; Guido Kroemer; Thomas Rudel
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

10.  Mcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells.

Authors:  Krishnaraj Rajalingam; Manu Sharma; Christine Lohmann; Monique Oswald; Oliver Thieck; Christopher J Froelich; Thomas Rudel
Journal:  PLoS One       Date:  2008-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.